Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
13M
-
Shares change
-
+528K
-
Total reported value, excl. options
-
$256M
-
Value change
-
+$10.7M
-
Number of buys
-
32
-
Number of sells
-
-16
-
Price
-
$19.75
Significant Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q4 2018
63 filings reported holding KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q4 2018.
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13M shares
of 50M outstanding shares and own 25.99% of the company stock.
Largest 10 shareholders include SV Health Investors, LLC (2.55M shares), RA CAPITAL MANAGEMENT, LLC (1.44M shares), Vivo Capital, LLC (1.36M shares), VHCP Management III, LLC (1.28M shares), EVENTIDE ASSET MANAGEMENT, LLC (900K shares), VHCP Management II, LLC (759K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (650K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (600K shares), Ghost Tree Capital, LLC (425K shares), and INTERWEST VENTURE MANAGEMENT CO (389K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.